Aetna, Inc. Reaffirms 2012 Outlook Heading into Investor and Analyst Meetings (AET)

Before and after a presentation given by Aetna Inc. (AET) CEO Mark Bertolini at the 2013 JP Morgan Healthcare Conference on Tuesday, January 8, the company’s executives will be meeting with investors and analysts to reaffirm 2012 guidance.

Based on available information, Aetna projects full year 2012 operating earnings to be about $5.10 per share. The company also expects 2012 revenues to be roughly $35.5 billion while Wall Street analysts expect revenues to be $35.57 billion.

At the meeting with investor and analysts, Aetna will also discuss the proposed acquisition of Conventry Health Care, Inc. All of the healthcare benefits company’s projections exclude the impact of the purchase of Conventry.

Aetna shares were flat in premarket trading on Tuesday. The stock is up +4.74% over the past year.

The Bottom Line
Shares of Aetna (AET) have a 1.73% dividend yield, based on last night’s closing stock price of $46.16. The stock has technical support in the $41-$44 price area. If the shares can firm up, we see overhead resistance around the $48-$50 price levels.

Aetna Inc. (AET) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here